We are live on ! Find out more
ACM

American Capital Management Portfolio holdings

AUM $1.86B
1-Year Est. Return 20.23%
This Fund
S&P 500
This Quarter Est. Return
-18.65%
1 Year Est. Return
+20.23%
3 Year Est. Return
+63.07%
5 Year Est. Return
+75.1%
10 Year Est. Return
+632.65%
AUM
$2.67B
AUM Growth
-$723M
Cap. Flow
+$8.33M
Cap. Flow %
0.31%
Top 10 Hldgs %
47.99%
Holding
67
New
2
Increased
29
Reduced
25
Closed
4

Top Sells

Rank Stock Value
1
FTNT icon
Fortinet
FTNT
+$11.9M
2
SEIC icon
SEI Investments
SEIC
+$6.1M
3
AZPN
ASPEN TECHNOLOGY INC
AZPN
+$5.01M
4
ILMN icon
Illumina
ILMN
+$3.41M
5
HQY icon
HealthEquity
HQY
+$2.19M

Sector Composition

Rank Sector Weight
1 Technology 44.51%
2 Healthcare 33.08%
3 Industrials 10.34%
4 Financials 7.26%
5 Consumer Discretionary 2.95%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FTNT icon
1
Fortinet
FTNT
$117B
$210M 7.86%
3,704,441
-199,694
-5% -$11.9M
ICLR icon
2
Icon
ICLR
$12.7B
$154M 5.75%
708,440
-6,782
-0.9% -$1.52M
MANH icon
3
Manhattan Associates
MANH
$11.4B
$153M 5.73%
1,333,552
+287
+0% +$35.7K
IDXX icon
4
Idexx Laboratories
IDXX
$46.2B
$135M 5.06%
384,662
-1,995
-0.5% -$814K
AVAV icon
5
AeroVironment
AVAV
$9.45B
$124M 4.65%
1,510,790
-8,512
-0.6% -$756K
RMD icon
6
ResMed
RMD
$30.7B
$111M 4.16%
529,949
-1,186
-0.2% -$252K
CYBR
7
DELISTED
CyberArk
CYBR
$111M 4.16%
867,451
+176
+0% +$25.4K
NICE icon
8
Nice
NICE
$5.97B
$103M 3.84%
533,061
+986
+0.2% +$200K
FDS icon
9
Factset
FDS
$10.2B
$96.1M 3.6%
249,925
-742
-0.3% -$290K
JKHY icon
10
Jack Henry & Associates
JKHY
$11.1B
$84.7M 3.17%
470,298
+9,913
+2% +$1.86M
QLYS icon
11
Qualys
QLYS
$6.35B
$82.1M 3.08%
650,797
+1,120
+0.2% +$147K
ANSS
12
DELISTED
Ansys
ANSS
$70.9M 2.66%
296,405
-577
-0.2% -$153K
MEDP icon
13
Medpace
MEDP
$16.5B
$69.6M 2.61%
464,952
+40,401
+10% +$5.85M
VRNT
14
DELISTED
Verint Systems
VRNT
$68.9M 2.58%
1,627,596
+18,311
+1% +$915K
CGNX icon
15
Cognex
CGNX
$11.3B
$67.5M 2.53%
1,587,621
+41,900
+3% +$2.35M
ABMD
16
DELISTED
Abiomed Inc
ABMD
$67.2M 2.52%
271,375
+72
+0% +$19.4K
TECH icon
17
Bio-Techne
TECH
$11.3B
$67.1M 2.51%
773,920
+2,828
+0.4% +$265K
VEEV icon
18
Veeva Systems
VEEV
$37.4B
$66.3M 2.49%
334,943
-6,268
-2% -$1.15M
KRNT icon
19
Kornit Digital
KRNT
$791M
$64.8M 2.43%
2,045,187
+10,484
+0.5% +$555K
GNTX icon
20
Gentex
GNTX
$5.07B
$61M 2.28%
2,179,220
+92,818
+4% +$2.7M
CSGP icon
21
CoStar Group
CSGP
$12.3B
$47.9M 1.8%
793,188
+19,696
+3% +$1.19M
MORN icon
22
Morningstar
MORN
$7.53B
$44.4M 1.66%
183,683
-2,744
-1% -$692K
ILMN icon
23
Illumina
ILMN
$28.4B
$42.6M 1.6%
237,664
-13,340
-5% -$3.41M
AZTA icon
24
Azenta
AZTA
$1.48B
$41.2M 1.54%
571,294
+21,416
+4% +$1.6M
BLKB icon
25
Blackbaud
BLKB
$2.08B
$37.2M 1.39%
640,822
-9,031
-1% -$525K

Similar funds

American Capital Management's Q2 2022 Portfolio in Review

As of Q2 2022, American Capital Management held 67 positions worth $2.67B, down 21% from $3.39B the previous quarter. Its ten largest holdings account for 48% of the portfolio.

American Capital Management's Q2 2022 filing shows 2 new, 29 increased, 25 reduced and 4 closed positions. Its largest new stake was STAAR Surgical: 57,398 shares worth $4.07M. The largest sale was Fortinet, an estimated $11.9M.

By sector, the portfolio is most concentrated in Technology at 45% of assets, up from 43% a quarter earlier, followed by Healthcare and Industrials.

  • American Capital Management's largest Q2 2022 buy was STAAR Surgical: 57,398 shares worth $4.07M.
  • American Capital Management added most to Paycom in Q2 2022, an estimated $9.28M increase.
  • American Capital Management's biggest Q2 2022 reduction was Fortinet, cutting an estimated $11.9M.
  • American Capital Management fully exited ASPEN TECHNOLOGY INC in Q2 2022, selling an estimated $5.01M.
  • American Capital Management's ten largest holdings make up 48% of its $2.67B portfolio in Q2 2022.
  • American Capital Management opened 2 new positions and closed 4 in Q2 2022.
  • American Capital Management's portfolio value fell 21% quarter-over-quarter to $2.67B.

Based on American Capital Management's 13F filing for Q2 2022, filed 15 Aug 2022.